» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'Pfizer' | Search again
DeSoto Public Records:0
Shelby Public Records:85
Editorial:89
West Tennessee:0
Middle Tennessee:4
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. Group with consumer-friendly vibe pushes drugmakers' message -

WASHINGTON (AP) — As ominous music plays in the background, the narrator of a radio ad warns that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors.

2. Senators draw on own experiences to chastise drug companies -

WASHINGTON (AP) — Channeling the ire of constituents and drawing from personal experience, senators chastised drug company executives Tuesday over the high cost of prescription medications, while the CEOs warned that government price controls could stifle breakthroughs on diseases like Alzheimer's.

3. US stocks end mixed as Wall Street assesses earnings -

Stocks posted an uneven finish on Wall Street Tuesday, handing the S&P 500 index its second decline in a row.

An early gain faded as investors assessed a mixed bag of corporate results and looked ahead to a heavy schedule of news on companies and the economy.

4. Glaxo, Pfizer to merge consumer health care divisions -

Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies.

5. Stocks climb as investors hope for Trump-Xi trade progress -

NEW YORK (AP) — Stocks climbed again Friday as investors waited for President Donald Trump and President Xi Jinping of China to meet and discuss trade, a meeting they hope will start to resolve the nations' trade dispute. The U.S. market jumped this week after falling to a six-month low the week before.

6. AP FACT CHECK: Trump fudges history on black vote, drug cost -

WASHINGTON (AP) — Facing pivotal November elections, President Donald Trump is misrepresenting the history of African-American voting and exaggerating his influence in boosting income and controlling prescription drug prices.

7. Health care and industrial stocks lead US indexes higher -

NEW YORK (AP) — U.S. stocks rose Tuesday following strong results from industrial and health care companies as well as a report that the U.S. and China are trying to restart trade talks. Small companies rallied.

8. Pfizer reorganizes to handle aging consumers and patents -

NEW YORK (AP) — Pfizer, facing an aging population and shifting risks from the loss of patents, is reshaping the company into three businesses.

The three divisions, announced Wednesday, include Innovative Medicines, which will focus on biological science and other technologies needed to address an aging population. The Established Medicines business will handle generic and off-brand medication. Lastly, the Consumer Healthcare business will handle over-the-counter medicines.

9. Apple leads tech higher as stocks recover from an early loss -

NEW YORK (AP) — U.S. stocks clawed back early losses Tuesday as Apple led a rally in technology companies. Smaller, more domestically-focused companies also climbed. The late push offset a slump in household goods makers and industrial companies.

10. Stocks jump as technology, industrials and banks rally -

NEW YORK (AP) — U.S. stocks are climbing Thursday morning as technology companies, banks and industrial companies rally. Companies including Delta Air Lines and BlackRock are rising after they reported strong results in the first quarter. Big technology companies including Apple and Microsoft are making some of the biggest gains.

11. Fisk receives $1M gift from board member -

Fisk University has announced a $1 million gift from Robert W. Norton, a retired Pfizer executive and member of the Fisk University Board of Trustees, and his wife Janice. The Norton’s gift will be used to provide scholarships for deserving students.

12. Health care, tech and trade hopes lead another stock surge -

NEW YORK (AP) — U.S. stocks powered to their biggest gain in almost nine months Friday as drugmakers and technology companies surged. Investors were cheered that President Donald Trump appeared to take a more positive tone on international trade.
AbbVie boosted biotechnology companies with a strong fourth quarter and a greater annual profit forecast, while Pfizer and other drugmakers also made big gains. Intel had its best day in almost nine years after its fourth-quarter results reassured investors that security flaws recently discovered in its processors aren't damaging its sales. Wynn Resorts tumbled following numerous allegations of sexual assault and harassment by Steve Wynn, the casino operator's chairman, CEO and biggest shareholder.
Speaking at the World Economic Forum in Davos, President Donald Trump said Friday that leaders should prioritize their own countries, but that his administration isn't opposed to international cooperation and that continued growth for the U.S. economy is good for the rest of the world.
"He did talk about making sure trade deals are fair, but I just thought it was a completely different tone today," said JJ Kinahan, chief investment strategist for TD Ameritrade. "I think the market really took a lot of positives away from that."
On Wednesday and Thursday, comments from Trump as well as Treasury Secretary Steven Mnuchin and Commerce Secretary Wilbur Ross contributed to swings in stock prices and the dollar as investors tried to parse the remarks for indications of administration's stances on the dollar and international trade.
The Commerce Department said the U.S. economy grew 2.6 percent in the fourth quarter. That was a bit less than analysts predicted but still a solid result, as Americans continued to shop and home construction increased. The economy grew 2.3 percent in 2017 and experts think growth will speed up this year, partly because of the tax cut package signed into law in December.
The Standard & Poor's 500 index climbed 33.62 points, or 1.2 percent, to 2,872.87, its biggest gain since March 1. The Dow Jones industrial average added 223.92 points, or 0.8 percent, to 26,616.71. The Nasdaq composite rose 94.61 points, or 1.3 percent, to 7,505.77. The Russell 2000 index of smaller-company stocks gained 6.39 points, or 0.4 percent, to 1,608.06.
Already at record highs, the S&P 500 is up 7.5 percent in January and on track for its largest monthly increase since October 2015.
Technology and industrial companies made hefty gains, as did Amazon and other retailers, and banks rose along with interest rates. Those companies tend to benefit from more global trade and faster economic growth. Many of them are helped by a weaker dollar, and the U.S. currency declined again Friday. The weaker dollar raises costs for more U.S.-focused companies such as those in the Russell 2000, which lagged other indexes Friday.
Intel said its data center business did well in the fourth quarter and the "Meltdown" and "Spectre" security flaws aren't affecting its sales. It forecast $65 billion in revenue this year, more than analysts expected. The stock added $4.78, or 10.6 percent, to $50.08, its biggest gain since March 2009.
Technology companies have led the market's big gains since the start of 2017, and that will be put to the test next week as a slew of major companies including Apple, Microsoft, Facebook and Google's parent company Alphabet all report their quarterly results.
AbbVie posted greater sales of key drugs including Humira, an inflammatory disease treatment that is the world's biggest-selling drug by revenue, and its hepatitis C treatments. AbbVie also raised its profit forecast for 2018. The stock jumped $14.91, or 13.8 percent, to $123.21.
Pfizer rose on reports that it's getting closer to a deal to sell its consumer health care business, a possibility Pfizer raised in October. It stock gained $1.78, or 5.3 percent, to $39.01.
Wynn Resorts stock plunged $20.31, or 10.1 percent, to $180.29 after the Wall Street Journal reported on dozens of allegations against Wynn, who denied any wrongdoing.
Starbucks skidded $2.56, or 4.2 percent, to $57.99 after it posted weaker growth than investors had hoped. Analysts were unhappy with its results outside the U.S., and Starbucks also sales of holiday merchandise were slow.
The dollar declined further against other currencies. It fell to 108.66 yen from 109.41 yen. The euro rose to $1.2423 from $1.2391. The ICE US dollar index is at three-year lows and has declined for six consecutive weeks.
Bond prices fell. The yield on the 10-year Treasury note rose to 2.66 percent, matching its highest level in more than three years. It finished at 2.62 percent Thursday.
After it reached an 18-month high Thursday, gold fell $10.80 to $1,352.10 an ounce. Silver dropped 17 cents, or 1 percent, to $17.44 an ounce. Copper slipped 2 cents to $3.20 a pound.
Benchmark U.S. crude rose 63 cents, or 1 percent, to $66.14 a barrel in New York. Brent crude, used to price international oils, added 10 cents to $70.52 per barrel in London.
Wholesale gasoline picked up 2 cents to $1.94 a gallon. Heating oil rose 2 cents to $2.14 a gallon. Natural gas rose 9 cents, or 2.5 percent, to $3.53 per 1,000 cubic feet.
The CAC 40 in France jumped 0.9 percent while the German DAX gained 0.3 percent. The FTSE 100 in Britain rose 0.7 percent. Japan's Nikkei 225 slipped 0.2 percent and South Korea's Kospi rose 0.5 percent. Hong Kong's Hang Seng index jumped 1.5 percent.
____
AP Markets Writer Marley Jay can be reached at http://twitter.com/MarleyJayAP His work can be found at https://apnews.com/search/marley%20jayt

...

13. VU, UT researchers offer hope for Alzheimer’s grip -

Few diseases are feared more than Alzheimer’s, a progressive brain disorder that steals memories, leaves no survivors and has no cure or real treatment.

But some of Tennessee’s top minds are working urgently on a way to treat the minds of the 5.2 million Americans who suffer from Alzheimer’s – including 110,000 in this state.

14. Legislators not shy in pushing ‘model’ bills from outsiders -

The group that brought Tennessee the voter photo ID law could be on the brink of spawning another kink on the voting process, one that cross-checks jury service with voter rolls.

At the behest of the American Civil Rights Union, legislators across the nation who belong to the American Legislative Exchange Council could be sponsoring bills in the next couple of years requiring local election commissions to take a closer look at people who miss jury duty.

15. Why tax plan might not put US firms' overseas cash to work -

WASHINGTON (AP) — The House Republican tax bill is meant to send trillions in corporate profits overseas pouring back home and, in the process, give the U.S. economy a healthy boost.

It may be more likely to land with an economic thud and provide a windfall to tax attorneys scouring the Byzantine bill for tax breaks on behalf of corporate clients.

16. Stocks rise after strong forecasts from Wal-Mart, airlines -

NEW YORK (AP) — A big jump for Wal-Mart helped the Dow Jones industrial average set a record Tuesday, while gains for other retailers and airlines sent other stock indexes higher as well.

Airlines rose following strong forecasts from American and United. Utilities and smaller companies also climbed, while banks edged higher as investors prepared for the financial sector to start reporting its third-quarter results in a few days. Wal-Mart notched its biggest gain in almost a year and a half after the company said it expects its digital sales to rise 40 percent in its next fiscal year. It also plans to buy back $20 billion in stock over two years.

17. US stocks slide further as banks and energy companies sink -

NEW YORK (AP) — U.S. stock indexes edged lower for the second day in a row Wednesday as a sharp drop for banks and a rare loss for technology companies canceled out gains for drugmakers and consumer-focused companies.

18. Advertisers flee Bill O'Reilly's show but impact unclear -

NEW YORK (AP) — More advertisers fled Bill O'Reilly's show on Wednesday, with drugmaker Pfizer and real estate company Coldwell Banker among the latest to distance themselves.

The snowball effect began Monday after a weekend report in The New York Times that O'Reilly and his employer paid five women $13 million to settle harassment or other allegations of inappropriate conduct by Fox's top star.

19. Record-setting stock streak hits sixth day on broad gains -

NEW YORK (AP) — U.S. stocks rose for the sixth day in a row Friday as major indexes continued to set records. The biggest gains went to companies that have been mostly left out of the post-election rally, including health care companies and makers of household goods.

20. Gains for banks and tech lead stocks to all-time highs -

NEW YORK (AP) — U.S. stocks edging higher in late morning trading Thursday, keeping major market indexes at record highs. Banks, technology and materials companies are leading the way higher. Defense contractors and other industrial companies are taking losses. Bond yields rose.

21. Pfizer fined for hiking epilepsy drug price 2,600 pct in UK -

LONDON (AP) — British regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record 89.4 million pounds ($112.7 million) Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.

22. Meharry names senior VP, medical school dean -

Meharry Medical College has appointed Veronica Thierry Mallett M.D., MMM, as its senior vice president for health affairs and dean of the School of Medicine, effective March 2017.

Mallett is a researcher and educator, known for her work in women’s health and reducing health disparities.

23. US stocks surge following Trump victory; bond prices tumble -

It turns out that President Donald Trump may not be bad for the stock market after all.

Asian stock markets stumbled shortly after Trump overtook Hillary Clinton in the presidential vote count early Wednesday. From there, Wall Street appeared set for a slump of its own, only it never materialized.

24. Stocks fade as nervous investors watch 2016 election -

NEW YORK (AP) — Stocks closed broadly lower on Tuesday, as nervous investors continued to monitor the run-up to the 2016 election, which is turning out to be closer than previously expected.

Newspaper stocks fell as Gannett and Tronc, publisher of The Los Angeles Times, called off a merger and drugmaker Pfizer fell as the company cut its full-year forecast.

25. Companies set monthly record for mergers, acquisitions -

U.S. companies are cutting merger deals at a record pace even though antitrust regulators have moved to oppose several recent high-profile combinations.

So far this month, companies have agreed to mergers and acquisitions valued at $249 billion, according to financial information provider Dealogic. That surpasses the previous record of $240 billion in July 2015.

26. US stocks slide as banks tumble on Deutsche Bank worries -

NEW YORK (AP) — U.S. stocks slumped Monday, and banks took the biggest losses. Deutsche Bank plunged as investors worried about the financial health of Germany's largest bank. Pfizer pulled drugmakers down after it announced it won't break up into two companies.

27. Low taxes at dozens of firms in spotlight after Apple ruling -

NEW YORK (AP) — It turns out some wealthy companies are just like some wealthy hedge fund managers: They're taxed at far lower rates than nearly everyone else.

Whether or not Apple used illegal breaks to pay virtually no taxes in Europe over 11 years, as regulators there contend and the company denies, the order last week that it pay billions in back taxes highlights a worrisome divide among the world's biggest corporations: Some pay relatively little taxes, others a lot.

28. Stocks end mostly lower in quiet trade; oil prices decline -

NEW YORK (AP) — Stocks closed slightly lower in quiet trading Monday after drifting most of the day between gains and losses. Energy companies fell along with the price of oil while biotechnology and drug companies rose after Pfizer announced it was buying a cancer drug maker.

29. Knapp succeeds Garfield as Bridgestone Americas president, CEO -

Bridgestone Americas, Inc. has announced the retirement of its CEO, President and Executive Chairman Gary Garfield, effective Dec. 31, 2016. Gordon Knapp, the company’s chief operating officer, will become Bridgestone Americas’ president and CEO on Sept. 1, 2016, and William “Bill” Thompson, the company’s chief financial officer, will succeed Knapp as COO on that date.

30. US stocks climb in broad rally as crude oil rises -

NEW YORK (AP) — A jump in oil prices and some deal news helped send stocks up broadly Monday, breaking a three-day losing streak.

Investors bought from the start of trading, pushing oil drillers and other energy stocks up sharply. A bullish oil report from Goldman Sachs helped send benchmark U.S. crude up 3.3 percent to its highest close in six months. All 10 sectors of the Standard and Poor's 500 index rose.

31. Corporate earnings keep falling, but there are signs of life -

NEW YORK (AP) — Are we there yet? It's another weak quarter on Wall Street, but there are some signs corporate America will come out of its recent funk.

Earnings at big U.S. companies are on track to tumble 6.4 percent in the first quarter, the worst since the financial crisis. That would also be the third straight decline in profits while revenue is on pace to fall for the fifth quarter in a row.

32. Slump in Chinese manufacturing weighs on markets -

NEW YORK (AP) — Renewed concerns about economic growth abroad — specifically Europe and China — weighed on markets on Tuesday, causing stocks to erase all of the previous day's gains.

33. Companies eye partnership deals to counter low growth -

LONDON (AP) — With global economic growth slowing, inflation staying low and digital innovation generating uncertainty, companies are increasingly looking at partnership deals with other firms, even competitors, to boost revenues, consulting firm EY said Monday.

34. Napster co-founder bankrolls project to speed cancer work -

TRENTON, N.J. (AP) — A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry researchers collaborating and sharing their findings like never before.

35. Experts expect corporate tax inversions to survive new rules -

President Barack Obama scored a victory this week when Pfizer scrapped a $160 billion overseas deal that would have kept a chunk of the drugmaker's profits beyond the U.S. tax man's reach.

But recent, aggressive federal actions that discouraged Pfizer Inc.'s combination with another drugmaker, Allergan PLC, won't stop all so-called inversions, or deals that end with a company relocating to another country — at least on paper — and trimming its U.S. tax bill in the process.

36. Allergan, Pfizer call off proposed $160B merger -

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland — on paper — to reduce its tax bill.

37. US stocks rise as health care and energy companies soar -

NEW YORK (AP) — U.S. stocks broke a two-day losing streak Wednesday as investors bought up drugmakers and other health care companies. Energy companies also jumped as the price of oil surged.

38. Stocks end lower in US; Disney slumps after exec leaves -

NEW YORK (AP) — U.S. stocks fell for a second day on Tuesday, as the head of the International Monetary Fund sounded downbeat on the outlook for the world economy.

Disney fell after the company's expected successor to CEO Bob Iger announced he was leaving the company. Allergan plunged after the Treasury Department announced tax rules that would make its merger with Pfizer more difficult.

39. US stocks end mixed, lower, amid drug company rout -

NEW YORK (AP) — Stocks ended mixed and mostly lower Tuesday, led by a steep decline in drug company shares as investors worried it will become harder for the companies to raise prices. Materials companies fell along with the price of precious metals.

40. First-of-a-kind drug approvals continued rise in 2015 -

WASHINGTON (AP) — Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.

The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.

41. How to spend $5 trillion: A record-breaking year in deals -

NEW YORK (AP) — Companies around the world spent a record $5.04 trillion on acquisitions in 2015, according to Dealogic, as slow worldwide economic growth and low interest rates pushed companies to combine forces.

42. Clinton offers new 'exit tax' on US-foreign company mergers -

WASHINGTON (AP) — Hillary Clinton on Wednesday will unveil a proposal for a new "exit tax" aimed at cracking down on corporate inversions, a practice that permits U.S. companies to merge with corporations overseas to lower their tax bill.

43. Pfizer, Allergan $160B deal forms world's largest drugmaker -

Pfizer and Allergan are joining in the biggest buyout of the year, a $160 billion stock deal that will create the world's largest drugmaker.

It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.

44. Markets fade after an early gain, finish with small losses -

NEW YORK (AP) — Stocks gained ground early Monday as they came off their best week in 2015, but faded in the afternoon and sustained small losses for the day.

Technology stocks fell more than the rest of the market. Pfizer and Allergan slipped after announcing a deal to combine and create the world's largest drug company. GameStop skidded after reporting weak results.

45. Treasury issues new rules to limit tax inversions -

WASHINGTON (AP) — The Obama administration on Thursday issued new rules aimed at reducing the tax benefits available to companies that move their tax addresses overseas.

The new rules follow an initial package of rules that the administration implemented in September 2014 in response to a wave of announcements by U.S. companies seeking to lower their taxes by moving their headquarters overseas. Those included an announcement in August of last year by Burger King that it planned to acquire Tim Hortons, the Canadian coffee and doughnut chain.

46. Big deal momentum may carry into 2016 for health care -

With $2 trillion in buyouts since January, 2015 has become the year of the megadeal, fueled by free money in a zero-interest rate environment.

But with the Fed appearing increasingly keen on hiking rates, that party may be coming to an end.

47. A late gain leaves stocks mostly higher after a 4-day slump -

NEW YORK (AP) — Stocks reversed course and moved mostly higher Tuesday, breaking a four-day losing streak.

The gainers included retailers and media companies. Strong quarterly results from D.R. Horton boosted shares of homebuilders.

48. US stocks climb, building on a big gain in October -

NEW YORK (AP) — Stocks are closing higher, led by gains in the energy and health care sectors.

Chevron jumped 4.5 percent Monday, the biggest gain in the Dow Jones industrial average. Pfizer was close behind with an increase of 3.7 percent.

49. US stocks slip as economic growth lags -

NEW YORK (AP) — Stocks are slightly lower in midday trading after the U.S. government said economic growth slowed more than expected in the summer. Companies including Buffalo Wild Wings and camera maker GoPro plunged after reporting weak earnings.

50. Stocks tick lower on mixed earnings; price of oil skids -

NEW YORK (AP) — Stocks slipped Tuesday afternoon after several U.S. companies delivered disappointing results and forecasts. Energy companies fell more than the rest of the market as the price of crude oil hit two-month lows.

51. FDA approves first pill aimed at boosting female libido -

WASHINGTON (AP) — The Food and Drug Administration has approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.

52. Stocks rise on tech earnings; Nasdaq adds to record -

NEW YORK (AP) — Stocks advanced slightly Friday as investors cheered the quarterly results of three large technology companies: Google, Microsoft and Amazon.

The modest gains helped close out a relatively strong week for U.S. stocks, with the three major indexes rising between 1.4 and 3.2 percent in five days. The Standard & Poor's 500 and Nasdaq composite closed at record highs.

53. Dollar Drag: surging buck hits US corporate earnings -

NEW YORK (AP) — The biggest obstacle for Coca-Cola and Pepsi these days isn't tied to taste tests, the declining popularity of sugary drinks or even their century-long rivalry. It's the surging U.S. dollar.

54. Health care, energy stocks among gainers on Wall Street -

NEW YORK (AP) — U.S. stocks rose broadly Thursday, helped by a 6 percent jump in the price of oil and a rise in health care stocks following Pfizer's $16 billion deal to buy drugmaker Hospira.

55. US company outlooks worry investors, sending stocks lower -

U.S. stocks slumped Tuesday after some of the market's largest companies reported disappointing earnings, taking investors on a turbulent ride that deepened the losses for the year.

The companies that rattled the market included Microsoft, Caterpillar and Procter & Gamble. Some also forecast weaker results in months ahead.

56. FDA approves new, hard-to-abuse hydrocodone pill -

WASHINGTON (AP) — Federal health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards.

57. Daschle, Baker Donelson form advisory group -

Former U.S. Senator and Senate Majority Leader Tom Daschle (D-SD) and law and government affairs firm Baker Donelson announced today the formation of The Daschle Group, A Public Policy Advisory of Baker Donelson.

58. Europe, Syria drag on global stock markets -

NEW YORK (AP) — Grim economic news from Europe and airstrikes in Syria rattled global stocks Tuesday.

Most of the damage was felt in European markets, which fell sharply after a closely watched gauge of business activity for the region fell to a nine-month low.

59. Same-sex marriage heading for Supreme Court vote? -

WASHINGTON (AP) — Both sides in the gay marriage debate agree on one thing: It's time for the Supreme Court to settle the matter.

Even a justice recently said she thinks so, too.

The emerging consensus makes it likely that the justices soon will agree to take up the question of whether the Constitution forbids states from defining marriage as the union of a man and a woman. A final ruling isn't likely before June 2015, but a decision to get involved could come as soon as the end of this month.

60. AIDS activist takes up a new fight: defending FDA -

WASHINGTON (AP) — As an AIDS activist in the early 1990s, Gregg Gonsalves traveled to Washington to challenge the Food and Drug Administration.

Gonsalves was part of the confrontational group AIDS Coalition to Unleash Power, which staged protests outside the FDA's headquarters, disrupted its public meetings and pressured its leaders into speeding up the approval of experimental drugs for patients dying of AIDS.

61. Diversified Trust expands Nashville leadership team -

Diversified Trust, an employee-owned, southeast-based comprehensive wealth management firm that manages more than $5 billion in client assets, has announced the hiring of three senior professionals in its Nashville office: Adam Dretler, senior vice president, Lamar Stanley, vice president, Katie Williams, vice president

62. Late push leaves US stock market mostly higher -

NEW YORK (AP) — Stocks are ending a choppy day mostly higher as investors balanced enthusiasm over a possible merger in the health care industry with bad news from Bank of America.

The Dow Jones industrial average rose 87 points, or 0.5 percent, to close at 16,448 Monday.

63. Technology, bank stocks drag US market lower -

NEW YORK (AP) — Stocks mostly fell Monday afternoon, led by declines in technology and bank stocks, as investors' excitement about a potential blockbuster pharmaceutical deal was snuffed out.

64. Health care, tech names lead decline in US stocks -

NEW YORK (AP) — Weakness in the health care and technology sectors dragged the U.S. stock market lower.

Health care stocks, which have risen more than other industries over the past year, fell sharply on Monday.

65. FDA wants more info on female libido pill -

WASHINGTON (AP) — A drugmaker working to develop a pill to boost sexual desire in women says regulators are demanding more studies on the experimental drug.

Sprout Pharmaceuticals said Tuesday that the Food and Drug Administration wants to see more data on how the company's drug, flibanserin, interacts with other medications and how it affects driving ability. Nearly 10 percent of women studied in company trials reported sleepiness while taking the daily pill.

66. After tough January, stock extend slide -

For investors, February is starting out just as rough as January.

U.S. stocks tumbled on Monday, pushing the Dow Jones industrial average down more than 320 points after reports of sluggish U.S growth added to investor worries about the global economy. The slump follows the Dow's worst January performance since 2009.

67. Stocks rise on Wall Street after 3 days of losses -

NEW YORK (AP) — Investors' jitters over emerging markets faded on Tuesday and U.S. stocks rose for the first time in four days.

Global stock markets stabilized after three turbulent days when investors grew worried about growth in China and other emerging markets. The sell-off began last Thursday, when a survey for January showed that Chinese manufacturing was set to contract, dragging down stocks in Asia, Europe and the U.S. The slide continued on Friday as currencies in countries including Argentina and Turkey slumped. On Monday, Asian markets slumped, although the selling on Wall Street eased.

68. Obama convening export panel at White House -

WASHINGTON (AP) — President Barack Obama says rising U.S. exports have been "one of the biggest bright spots" of the U.S. economy.

Obama in 2010 set a goal of doubling exports by 2015, but the country is not on track to meet that goal. However, Obama pointed out the United States now sells more goods overseas than ever before, and those sales have boosted the U.S. economy. Obama says "made in America" means something around the world.

69. Obama convening export panel at White House -

WASHINGTON (AP) — President Barack Obama is convening his advisory council on international trade as the U.S. pursues an aggressive goal to double its exports.

Obama will meet with the President's Export Council on the White House grounds Thursday. It's the first meeting to include new members added to the council from the pharmaceutical, defense and hospitality industries.

70. King Pharmaceuticals settles over plant emissions -

NASHVILLE (AP) - King Pharmaceuticals LLC has agreed to pay $2.2 million and comply with the Clean Air Act to resolve a complaint filed by federal prosecutors over emissions from its Bristol, Tenn., facility.

71. Bashful? Buy the little blue pill online -

TRENTON, N.J. (AP) — Men who are bashful about needing help in the bedroom no longer have to go to the drugstore to buy that little blue pill.

In a first for the drug industry, Pfizer Inc. told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra to patients on its website.

72. High court weighs drug companies' generics policy -

WASHINGTON (AP) — Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines that can top 90 percent.

73. Judge OKs $4B BP oil spill criminal settlement -

NEW ORLEANS (AP) — A federal judge on Tuesday approved an agreement for BP PLC to plead guilty to manslaughter and other charges and pay a record $4 billion in criminal penalties for the company's role in the 2010 rig explosion and oil spill in the Gulf of Mexico.

74. Stocks advance, pushing Dow toward 14,000 -

NEW YORK (AP) — Pfizer helped keep the stock market rally alive Tuesday. The drugmaker's stock gained after posting strong earnings, pushing the Dow closer to 14,000.

The Dow Jones industrial average rose 73 points to close at 13,954.42 points, ending higher for the seventh day in eight. The Standard and Poor's 500 also rose, adding eight points to 1,507.84 points. The Nasdaq composite dropped less than a point to 3,153.66.

75. Defense lawyers say BP rig workers are scapegoats -

NEW ORLEANS (AP) — While BP has resolved a sweeping criminal probe of its role in the massive 2010 oil spill in the Gulf of Mexico, two company employees charged in the deaths of 11 rig workers claim the Justice Department is trying to make them scapegoats for the disaster.

76. BP to pay US billions for Gulf spill -

NEW ORLEANS (AP) — Oil giant BP has agreed to pay the largest criminal penalty in U.S. history, totaling billions of dollars, for the 2010 oil spill in the Gulf of Mexico, a person familiar with the deal said Thursday.

77. Storm will keep financial markets closed Tuesday -

NEW YORK (AP) — Stock trading will be closed in the U.S. for a second day Tuesday as Hurricane Sandy bears down on the East Coast. Bond trading will also be closed.

The last time the New York Stock Exchange was closed for weather was in 1985 because of Hurricane Gloria, and it will be the first time since 1888 that the exchange will have been closed for two consecutive days because of weather. The cause then was a blizzard that left drifts as high as 40 feet in the streets of New York City.

78. Stocks higher after retail sales improve -

Stocks rose on Monday after a strong gain in retail spending suggested that consumers could be getting more confident about the economy. Bank stocks rose broadly after Citigroup delivered a strong earnings report.

79. Stocks up slightly on strong retail results -

Stocks resembled summer vacationers on Friday, rising not-too-impressively in the morning and then mostly laying around for the rest of the day.

Positive news from retailers was the main reason U.S. indexes posted small gains. Apple helped too by hitting a new high.

80. Small study: Drug may help stabilize Alzheimer's -

For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and in only four patients.

The drug is Gammagard, made by Baxter International Inc. Doctors say that four patients who have been receiving the highest dose for three years showed no decline on memory and cognition tests. A dozen others on different doses or shorter treatment times didn't fare as well.

81. Weary investors sell stocks as Spain seeks help -

NEW YORK (AP) — Europe's latest efforts to quell its financial crisis left investors exasperated Monday, causing steep losses in stock markets on both sides of the Atlantic.

In Europe, Spain formally asked for help to rescue the country's ailing banks, but its request left many questions unanswered, including how much it needs of the $125 billion loan package offered by other European governments. The uncertainty unsettled markets, pushing borrowing costs higher for Spain's government. Spain's stock market plunged 3.7 percent.

82. Dow on its way to breaking six-day losing streak -

Stocks rose on Thursday, putting the Dow Jones industrial average on track to break a six-day losing streak.

The gains came after the government said claims for unemployment benefits edged lower last week. Investors have been worried that a strong start to hiring this year was coming to an end.

83. Stocks jump after strong jobs report -

NEW YORK (AP) — A drop in the unemployment rate to its lowest level in three years propelled stocks higher Friday. The Dow Jones industrial average jumped more than 130 points, drawing the average to its highest mark since before the financial crisis hit in 2008.

84. US stocks flat after mixed economic data -

Investors coasted Thursday while they waited for a critical government report on jobs. Stocks were mostly flat, a pause from their strong start this year, and bonds didn't move much, either.

The Labor Department said the four-week average of unemployment claims fell to 375,750, the lowest since June 2008 and enough to suggest a steadily improving job market.

85. Pfizer recalls 1M birth control packs after mixup -

WASHINGTON (AP) — Pfizer Inc. is recalling 1 million packets of birth control pills because of a packaging error that could leave women with an inadequate dose of the hormone-based drugs and raise the risk that they will get pregnant accidentally.

86. Pharma's niche focus spurs US aid for antibiotics -

WASHINGTON (AP) — The pharmaceutical industry won approval to market a record number of new drugs for rare diseases last year, as a combination of scientific innovation and business opportunity spurred new treatments for diseases long-ignored by drug companies.

87. With new generic rivals, Lipitor's sales halved -

TRENTON, N.J. (AP) — Sales of cholesterol blockbuster Lipitor plunged by half barely a week after the world's top-selling drug got its first U.S. generic competition, new data show.

That's despite a very aggressive effort by Lipitor maker Pfizer Inc. to keep patients on its pill, which generated peak sales of $13 billion a year, through patient subsidies and big rebates to insurers.

88. Why that corporate cash pile isn't so impressive -

NEW YORK (AP) — Hardly a day goes by without some politician or pundit pointing out that companies are hoarding cash — roughly $3 trillion of it. If only they would spend it, the thinking goes, the economy might get better.

89. HCA raises $3.79 billion in 3rd IPO -

The owners of hospital chain HCA Holdings Inc. found investors eager for its stock as the company sold more shares in its initial public offering than it expected - and at the top of the expected range.